相关实验视频
Updated: Jan 13, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.4K
自我一致的模型系统协同作用或对抗作用与相关性强度指数:使用MAO-A抑制剂的联合阅读
1Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, India.
SAR and QSAR in environmental research
|January 6, 2026
概括
研究人员使用计算模型开发了用于神经退行性疾病的新型单胺氧化酶-A (MAO-A) 抑制剂. 化合物M1表现出显著的抑制活性和结合 afinity,提供了一个有前途的治疗途径.
科学领域:
- 药用化学 医学化学
- 计算化学计算化学
- 神经科学是一个神经科学.
背景情况:
- 神经退行性疾病是全球主要的健康问题.
- 单胺氧化酶 (MAO) 是管理这些疾病的关键目标.
- 现有的MAO抑制剂具有局限性,需要开发新药.
研究的目的:
- 开发新的单胺氧化酶-A (MAO-A) 抑制剂.
- 设计具有更好的疗效和安全配置文件的分子.
- 为了利用计算建模用于药物发现.
主要方法:
- 开发了192种MAO-A抑制剂的定量结构-活性关系 (QSAR) 模型,使用蒙特卡洛和经合组织原则.
- 用于模型验证的相关性理想性指数 (IIC) 和相关性强度指数 (CII).
- 根据已识别的结构属性设计了五种新分子 (M1-M5).
- 进行了分子对接研究,以评估结合亲和力和预测抑制活性.
主要成果:
- 开发的QSAR模型表现出强大的预测能力.
- 化合物M1显示出预测最高的抑制活性 (pIC50 = 5.5) 和结合亲和力 (-9.5 kcal mol-1).
- 与原始化合物相比,设计的分子显示出更高的结合亲和力和MAO-A抑制潜力.
- 在计算的pIC50和结合亲和力之间观察到高相关性 (0.9540).
结论:
- 该研究通过计算药物设计成功识别了强大的MAO-A抑制剂.
- 化合物M1代表了对神经退行性疾病进一步发展的有希望的主要候选者.
- QSAR建模和分子对接的综合方法加速了有效治疗剂的发现.
关键词:
在CII,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,IIC,II,IIC,II,IIC,II,IIC,II,IIC,II,II,IIC,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II,II单胺氧化酶-A 的存在.在QSAR中使用QSAR.停靠的对接方式这是一个自相一致的模型系统.更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.7K
05:50Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
1.4K
相关概念视频
01:30Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
01:14Agonism and Antagonism: Quantification
969
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
969
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
01:29The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
328
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
328
01:30Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K